Jamil Jaber1, Jordan Glenn2, David Podkameni2,3, Flavia Soto4,5. 1. College of Medicine Phoenix, University of Arizona, 550 E Van Buren St, Phoenix, AZ, 85004, USA. 2. Banner Gateway Hospital, 1900 N Higley Rd, Gilbert, AZ, 85234, USA. 3. Banner Estrella Hospital, 9201 W Thomas Rd, Phoenix, AZ, 85037, USA. 4. Banner Gateway Hospital, 1900 N Higley Rd, Gilbert, AZ, 85234, USA. sotof@upstate.edu. 5. Banner Estrella Hospital, 9201 W Thomas Rd, Phoenix, AZ, 85037, USA. sotof@upstate.edu.
Abstract
OBJECTIVE: This study was undertaken to examine the factors contributing to laparoscopic adjustable gastric band (LAGB) removals among adults > 18 years of age. We hypothesized that female patients with multiple comorbidities would have increased removals. DESIGN: This retrospective exploratory study uses internal records and standard statistical methods of analysis. RESULTS: Eighty-five bands were removed (11.8% males, 88.2% females). The average BMI was 40.7 (n = 83). 2.4% of patients had removals between 0 and 12 months, 18.8% between 39 and 51 months, and 35.3% between 39 and 64 months. 8.2% of treatment times were unknown. The average treatment time was 67.9 months. 48.2% of patients had ≥ 2 comorbidities, GERD (44.2%) being the most frequent. 49.4% of patients reported dysphagia as the reason for band removal. 22.4% of removals were associated with band failures, none with port complications. The reason for band removal was unknown in 21.2% of patients. 67.1%, 32.9%, and 23.5% attended 30-, 60-, and 90-day follow-up appointments, respectively. Weight post-band removal surgery at 30, 60, and 90 days was noted to be - 0.4%., 0.9%, and 0.4%, respectively. CONCLUSION: This study supports current literature suggesting LAGB may not be an effective long-term surgical intervention for obesity. Patients with > 2 comorbidities had increased rates of removal. Dysphagia was noted to be the primary reason cited for LAGB removal. Postoperative follow-up was found to be a significant challenge for LAGB removal patients. Further study is warranted to explore if these poor follow-up rates should be considered when risk stratifying LAGB patients for revisional surgery.
OBJECTIVE: This study was undertaken to examine the factors contributing to laparoscopic adjustable gastric band (LAGB) removals among adults > 18 years of age. We hypothesized that female patients with multiple comorbidities would have increased removals. DESIGN: This retrospective exploratory study uses internal records and standard statistical methods of analysis. RESULTS: Eighty-five bands were removed (11.8% males, 88.2% females). The average BMI was 40.7 (n = 83). 2.4% of patients had removals between 0 and 12 months, 18.8% between 39 and 51 months, and 35.3% between 39 and 64 months. 8.2% of treatment times were unknown. The average treatment time was 67.9 months. 48.2% of patients had ≥ 2 comorbidities, GERD (44.2%) being the most frequent. 49.4% of patients reported dysphagia as the reason for band removal. 22.4% of removals were associated with band failures, none with port complications. The reason for band removal was unknown in 21.2% of patients. 67.1%, 32.9%, and 23.5% attended 30-, 60-, and 90-day follow-up appointments, respectively. Weight post-band removal surgery at 30, 60, and 90 days was noted to be - 0.4%., 0.9%, and 0.4%, respectively. CONCLUSION: This study supports current literature suggesting LAGB may not be an effective long-term surgical intervention for obesity. Patients with > 2 comorbidities had increased rates of removal. Dysphagia was noted to be the primary reason cited for LAGB removal. Postoperative follow-up was found to be a significant challenge for LAGB removal patients. Further study is warranted to explore if these poor follow-up rates should be considered when risk stratifying LAGB patients for revisional surgery.
Authors: Andrea Lazzati; Marie De Antonio; Luca Paolino; Francesco Martini; Daniel Azoulay; Antonio Iannelli; Sandrine Katsahian Journal: Ann Surg Date: 2017-03 Impact factor: 12.969
Authors: Y Van Nieuwenhove; W Ceelen; A Stockman; H Vanommeslaeghe; E Snoeck; K Van Renterghem; D Van de Putte; P Pattyn Journal: Obes Surg Date: 2011-05 Impact factor: 4.129
Authors: Nancy Puzziferri; Thomas B Roshek; Helen G Mayo; Ryan Gallagher; Steven H Belle; Edward H Livingston Journal: JAMA Date: 2014-09-03 Impact factor: 56.272
Authors: Ruben Schouten; Dorothee C Wiryasaputra; Francois M H van Dielen; Wim G van Gemert; Jan Willem M Greve Journal: Obes Surg Date: 2010-12 Impact factor: 4.129